Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Ilaris
Pharma
Novartis' Ilaris fails 3rd trial in lung cancer
The drug didn't show improvement compared with placebo in disease-free survival, missing the study's primary endpoint.
Zoey Becker
Aug 15, 2022 11:26am
AACR: Novartis makes case for canakinumab in lung cancer
Apr 12, 2022 4:05pm
Novartis looks for silver lining after 2nd Ilaris NSCLC flop
Oct 25, 2021 10:45am
Novartis says it overpaid Genentech nearly $210M in IP
Jun 28, 2021 11:18am
Novartis chalks up a flop for canakinumab in NSCLC
Mar 9, 2021 10:35am
Inside Novartis' fight to keep its supply chain open amid COVID
Jun 4, 2020 11:20am
